As Reported Financials

As Reported Financials

Source Document Currency Code (in thousands) 2014 Y 12/31/2016 USD 2015 Y 12/31/2017 USD 2016 Y 12/31/2017 USD 2017 Y 12/31/2017 USD 2018 Q3 YTD 9/30/2018 USD
Source Document Currency Code 2014 Y 12/31/2016 USD 2015 Y 12/31/2017 USD 2016 Y 12/31/2017 USD 2017 Y 12/31/2017 USD 2018 Q3 YTD 9/30/2018 USD

CASH FLOWS FROM OPERATING ACTIVITIES

Net Income 44,246 44,772 72,514 51,882 38,848

Adjustments to reconcile net income to net cash provided by operating activities

Net (gain) loss on the sales of investment securities and MBS available-for-sale (997) (1,384) 0 36 NA
Net gain on sale of investment securities held-to-maturity NA 0 0 (2,607) NA
Net gain recognized on marketable equity and trading securities (13) 111 (83) (169) (110)
Net gain on the sale of other real estate owned (“OREO”) 0 0 (40) 0 NA
Write-down of OREO 0 0 18 0 NA
Net gain on sale of premises (649) 0 (68,183) (10,412) NA
Net gain on sale of loans held for sale (27) 0 0 (1,475) (143)
Net gain on sale of MBS available-for-sale NA NA NA NA (1,374)
Net depreciation, amortization and accretion 2,641 2,738 2,296 3,673 3,054
Stock plan compensation 2,087 1,886 1,837 1,687 1,198
Prepayment of ESOP Share Acquisition Loan 0 0 11,319 0 NA
ESOP compensation expense 1,230 1,307 1,138 0 NA
Provision for loan losses (1,872) (1,330) 2,118 520 1,641
Credit to reduce the liability for loans sold with recourse (1,040) NA NA NA NA
Loss from extinguishment of debt NA 0 0 1,272 0
Proceeds from sale of loans held for sale NA NA NA NA 2,283
Increase in cash surrender value of BOLI (1,743) (2,405) (2,250) (2,217) (2,161)
Income recognized from mortality benefit on BOLI 0 0 (484) 0 NA
Deferred income tax provision 771 6,883 1,097 10,515 (1,910)
Reduction in credit related other than temporary impairment (“OTTI”) amortized through interest income 0 (228) (104) (60) 0
Excess tax benefit of stock benefit plans (71) (303) (171) 0 NA
Changes in assets and liabilities
Decrease (Increase) in other assets (2,873) (1,464) (2,942) (8,477) 5,129
Increase in other liabilities 5,573 (430) 1,979 (906) (3,010)
Net cash provided by Operating activities 47,263 50,153 20,059 43,262 43,445

CASH FLOWS FROM INVESTING ACTIVITIES

Proceeds from sales of marketable equity securities NA NA NA NA 923
Proceeds from sales of investment securities held-to-maturity NA 0 0 9,167 NA
Proceeds from sale of investment securities held to maturity 88 340 0 0 0
Proceeds from sales of investment securities available-for-sale 3,780 2,070 0 377 0
Proceeds from sales of MBS available-for-sale 0 24,307 0 15,000 158,758
Proceeds from sales of trading securities 7,115 1,340 3,648 4,629 0
Proceeds from calls and principal repayments of MBS available-for-sale 15,000 1,602 59 957 51,472
Purchase of BOLI (25,000) 0 0 (20,000) NA
Purchases of loans (225,604) (99,745) (157,782) 0 NA
Purchases of investment securities available-for-sale (3,884) (2,134) (22) (145) (5,071)
Purchases of marketable equity securities NA NA NA NA (202)
Purchases of MBS available-for-sale (875) 0 (3,267) (363,680) (330,987)
Acquisition of trading securities (8,839) (3,090) (317) (222) NA
Principal collected on MBS available-for-sale 5,863 NA NA NA NA
Proceeds from sale of portfolio loans held for sale 16,892 9,572 0 333,176 0
Net decrease (increase) in loans (210,770) (486,142) (781,960) (298,910) 185,239
Proceeds from the sale of OREO and real estate owned 0 0 170 0 NA
Proceeds from surrender of cash surrender value of BOLI 0 0 1,425 0 NA
Proceeds from the sale of fixed assets and premises held for sale 4,273 0 75,899 11,791 NA
Purchases of fixed assets, net (1,618) (1,488) (5,774) (9,231) (2,356)
Redemption (purchase) of FHLBNY capital stock, net (10,356) (306) 14,269 (15,252) 5,854
Net cash provided by (used in) Investing Activities (433,935) (553,674) (853,652) (332,343) 63,630

CASH FLOWS FROM FINANCING ACTIVITIES

Decrease in due to depositors 152,646 524,518 1,211,116 8,021 (21,197)
Increase in escrow and other deposits 22,517 (14,791) 25,871 (20,833) 37,628
Repayments of FHLBNY advances (1,224,500) (2,897,500) (3,178,500) (4,602,075) (2,519,600)
Proceeds from FHLBNY advances 1,488,225 2,890,500 2,842,900 4,940,950 2,392,525
Proceeds from exercise of stock options 278 6,549 3,498 792 954
Release of stock for benefit plan awards NA NA NA NA 13
BMP ESOP shares received to satisfy distribution of retirement benefits 0 0 (1,820) (3,905) (883)
Treasury shares repurchased 0 (300) 0 0 (17,406)
Cash dividends paid to stockholders, net (20,106) (20,292) (20,581) (21,004) (15,742)
Proceeds from Subordinated debt issuance, net NA 0 0 113,531 0
Excess tax benefit of stock benefit plans 71 303 171 0 NA
Equity award distribution 201 251 287 236 NA
Repayments of Trust Preferred securities NA 0 0 (70,680) 0
Net cash provided by (used in) Financing Activities 419,332 489,238 882,942 345,033 (143,708)
DECREASE (INCREASE) IN CASH AND CASH EQUIVALENTS 32,660 (14,283) 49,349 55,952 (36,633)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD 45,777 78,437 64,154 113,503 169,455
CASH AND CASH EQUIVALENTS, END OF PERIOD 78,437 64,154 113,503 169,455 132,822

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION

Cash paid for income taxes 29,035 25,659 58,383 36,515 7,928
Cash paid for interest 48,329 46,698 52,320 59,823 52,450
Loans transferred to OREO 0 130 0 0 NA
Loans transferred to held for sale 16,865 9,572 0 333,192 2,140
Transfer of premises to held for sale 0 8,799 1,379 0 NA
Amortization of unrealized loss on securities transferred from available-for-sale to held-to-maturity 65 125 51 50 0
Net decrease in non-credit component of OTTI (32) 9 (34) (20) 0
Reclassification of OCI from sale of investment securities held to maturity NA 0 0 1,229 NA
Reductions for previous credit losses realized on securities sold NA NA NA NA 0
Data shown on this page is extracted directly from the company’s documents. S&P makes every effort to line up fields, captions and headers that represent the same data over time, despite variations in how the company may report these items in different documents. In certain instances the variation in the company’s presentation over time may be too significant, potentially resulting in repeating and/or disordered items. Despite possible issues with the presentation, S&P, as always, stands by its commitment to the quality of the data.